Prof. Dr. Jörg Fehr (emeritiert)

Fakultäten » Medizinische Fakultät » Hämatologie, Klinik für » Prof. Dr. Jörg Fehr (emeritiert)

Completed research projects

Project leader	Project title
Asmis	Pathogenicity of Heparin-induced Antibodies
	Clinical Appilcations of Platelet Flow Cytometry
	Endothelial thromboresistance
Asmis Merz	Endogenous thrombin potential (ETP) in monitoring transition from intravenous (heparin) to oral (vit. K antagonists) anticoagulation (and vice versa).
Bombeli	Regulation of the von-Willebrand Cleaving Protease (ADAMTS-13)
	Interaction of thrombocytes with the vascular endothelium in dependence of different von Willebrand Factor (vWF) concentrates in a thrombosis flow model.
	Decreased anticoagulant response to tissue factor pathway inhibitor in patients with venous thrombo-embolism and otherwise no evidence of hereditary or acquired thrombophilia
	In patients symptomatic for deep-vein thrombosis factor VIII elevation is found twice as frequent as in patients symptomatic for pulmonary embolism
Dindo Breitenstein Asmis	D-Dimers in surgical patients
Fehr	Work-up and diagnosis of erythrocytotic states
	Thrombokinetics in human diseases with In-111-labeling of autologous platelets
	Diagnosis and Classification of Low and Intermediate Grade Malignancy B-Cell Lymphomas, with special reference to quantitative assessment of Cyclin D1
	Quantitative assessment of hemolytic anemias
	Quantitative assessment of inflammatory diseases
	Bone marrow histology assessed with metacrylate embedding
	Long-term follow up of patients with hairy cell leukemia: best individualized therapeutic modality ? Best way of monitoring course of disease ?
Fehr Goede	Oral Low Dose Etoposide in the Treatment of Macrophage Activation Syndrome
	Oral Low Dose Etoposide in the Treatment of Macrophage Activation Syndrome
	More than 25 years of experience with the epinephrine stimulation test: a reliable test to assess hypersplenism
Goede	The distinction between haemolysis due to hereditary spherocytosis and that due to a cation permeability disorder of the red cell membrane in a regular haematology laboratory
	Congenital dyserythropoietic anaemia type I with bone abnormalities, mutations of the CDAN I gene and significant responsiveness to alpha-interferon therapy
Goede Bogdanova	Role of erythrocyte nitric oxide synthase in physiology and pathophysiology of human red blood cells
Goede Lutz	What stimulates alternative complement pathway in severe sepsis?
Schanz	Allografting as consolidative immunotherapy for older patients with AML in complete remission using low dose TBI, PBSC infusion and posttransplant immunosuppression with cyclosporine and mycophenolate.
Schanz Siegwart	Decision finding in stem cell transplantation
Seebach Schanz	ABO-Incompatibility and Hyperacute Xenograft Rejection. Minor ABO-incompatible bone marrow transplantation as a model for B cell tolerance and the prevention of natural antibody-mediated graft rejection.